All lobbying filings

FORBES-TATE

FORBES-TATE filed a Q3 report for JOHNSON & JOHNSON on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for JOHNSON & JOHNSON · Multinational pharmaceutical, biotechnology, and medical technologies corporation.

All filings by FORBES-TATE · Everything JOHNSON & JOHNSON has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to the 340B Drug Pricing Program.

Medicare/Medicaid

Issues related to the 340B Drug Pricing Program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.